Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Pittsburgh, Pennsylvania 15219


Purpose:

To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.


Criteria:

Inclusion Criteria Patients must have: - Hemophilia. - HIV-seropositivity confirmed by Western Blot. Prior Medication: Required: - AZT for study patients. Allowed: - Ibuprofen. Exclusion Criteria Co-existing Condition: Patients with the following symptoms and conditions are excluded: Hospitalization for opportunistic infection, bacterial infection or malignancy. Concurrent Medication: Excluded: - AZT (for control group). - Antibiotics or other medication for opportunistic infection, bacterial infection, or malignancy. Patients with the following prior conditions are excluded: Hospitalization for opportunistic infection, bacterial infection, or malignancy. Required: - Ibuprofen. - AZT 1-2 gm daily (for study patient) or not taking AZT (for control).


NCT ID:

NCT00002276


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Pittsburgh, Pennsylvania 15219
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.